Securities code: 000710 securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022-001 Berry Genomics Co.Ltd(000710)
About some shares of the stock pledge repurchase transaction of the controlling shareholder and its persons acting in concert
Announcement of cancellation of pledge
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Berry Genomics Co.Ltd(000710) (hereinafter referred to as "the company") recently received a notice from Mr. Gao Yang, the controlling shareholder of the company, and Ms. Hou Ying, the person acting in concert. It was learned that Mr. Gao Yang and Ms. Hou Ying, the person acting in concert, had gone through the procedures for releasing the pledge of some shares in the stock pledge type repurchase transaction. After verification with the pledgee and consulting the relevant data issued by China depository and Clearing Co., Ltd., the specific matters are confirmed as follows:
1、 Cancellation of pledge
Whether it is the largest shareholder to be released this time, the proportion of shares held by the pledgee in the number (shares) of the same bank of the company and the proportion of total share capital except the name of the pledge shareholder and the date of the Pledged Shares
Gaoyang is 65000000 2017.8.172021.12.31 Guosen Securities Co.Ltd(002736) shares, 13.8858% 1.8330% Hou Ying is 28000000 2017.8.172021.12.31 shares, 10.7051% 0.7896% of the limited company
Total - 9300000 - 12.7456% 2.6226%
Note: the above "proportion of shares held by this release of pledge" refers to "proportion of shares held before this release of pledge". 2、 Cumulative pledge
As of the date of this announcement, the controlling shareholder Mr. Gao Yang holds 40310572 shares of the company, accounting for 11.37% of the total share capital of the company. The company's shares held by him have been pledged 2418000 shares, accounting for 59.98% of the total shares held by him and 6.82% of the total share capital of the company.
As of the date of this announcement, Ms. Hou Ying, the person acting in concert, holds 23355661 shares of the company, accounting for 6.59% of the total share capital of the company. The company's shares held by him have been pledged 13960000 shares, accounting for 59.77% of the total shares held by him and 3.94% of the total share capital of the company.
As of the date of this announcement, Mr. Gao Yang, the controlling shareholder of the company, and Ms. Hou Ying, the person acting in concert, held 63666233 shares of the company, accounting for 17.95% of the total share capital of the company. 38140000 shares of the company were pledged, accounting for 59.91% of the total shares of the company and 10.76% of the total share capital of the company.
3、 Other relevant instructions
As of the date of this announcement, the shares pledged by Mr. Gao Yang, the controlling shareholder of the company, and Ms. Hou Ying, the person acting in concert, do not have the risk of closing positions, which will not lead to the change of the company's actual control and will not affect the company's operating results and financial status. The company will continue to pay attention to its share pledge and pledge risk, and fulfill its obligation of information disclosure in a timely manner, Please pay attention to investment risks.
4、 Documents for future reference
1. Detailed statement of securities pledge and judicial freezing of China Securities Depository and Clearing Co., Ltd.
2. Certificate of share pledge cancellation registration.
It is hereby announced.
Berry Genomics Co.Ltd(000710) board of directors January 5, 2022
